[go: up one dir, main page]

WO2009072576A1 - 骨形成促進剤 - Google Patents

骨形成促進剤 Download PDF

Info

Publication number
WO2009072576A1
WO2009072576A1 PCT/JP2008/072083 JP2008072083W WO2009072576A1 WO 2009072576 A1 WO2009072576 A1 WO 2009072576A1 JP 2008072083 W JP2008072083 W JP 2008072083W WO 2009072576 A1 WO2009072576 A1 WO 2009072576A1
Authority
WO
WIPO (PCT)
Prior art keywords
acid
bone formation
formation stimulator
stimulator
beverage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/072083
Other languages
English (en)
French (fr)
Inventor
Jun Fuchimoto
Yukio Okada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sapporo Breweries Ltd
Original Assignee
Sapporo Breweries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sapporo Breweries Ltd filed Critical Sapporo Breweries Ltd
Priority to JP2009544718A priority Critical patent/JPWO2009072576A1/ja
Publication of WO2009072576A1 publication Critical patent/WO2009072576A1/ja
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

 本発明は、アルファ酸、イソアルファ酸、テトラヒドロイソアルファ酸、ローイソアルファ酸及びヘキサヒドロイソアルファ酸からなる群より選ばれる少なくとも1種を有効成分とする、新規の骨形成促進剤を提供する。本発明はまた、そのような骨形成促進剤を含有する医薬、飲食品添加物、飲食品、飼料添加物、飼料等を提供する。
PCT/JP2008/072083 2007-12-04 2008-12-04 骨形成促進剤 Ceased WO2009072576A1 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009544718A JPWO2009072576A1 (ja) 2007-12-04 2008-12-04 骨形成促進剤

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007-313890 2007-12-04
JP2007313890 2007-12-04

Publications (1)

Publication Number Publication Date
WO2009072576A1 true WO2009072576A1 (ja) 2009-06-11

Family

ID=40717753

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/072083 Ceased WO2009072576A1 (ja) 2007-12-04 2008-12-04 骨形成促進剤

Country Status (2)

Country Link
JP (1) JPWO2009072576A1 (ja)
WO (1) WO2009072576A1 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018131389A (ja) * 2017-02-13 2018-08-23 サッポロホールディングス株式会社 アセトアルデヒドデヒドロゲナーゼ活性促進剤

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06312924A (ja) * 1993-04-28 1994-11-08 Asahi Breweries Ltd 抗酸化作用を有するフムロン類の利用
JPH07330594A (ja) * 1994-04-12 1995-12-19 Hoechst Japan Ltd 骨粗鬆症治療剤
WO2003068205A1 (en) * 2002-02-14 2003-08-21 Kirin Beer Kabushiki Kaisha Compositions and foods for improving lipid metabolism

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007276885A1 (en) * 2006-07-25 2008-01-31 Sanofi-Aventis 2-phenyl-indoles as prostaglandin D2 receptor antagonists

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06312924A (ja) * 1993-04-28 1994-11-08 Asahi Breweries Ltd 抗酸化作用を有するフムロン類の利用
JPH07330594A (ja) * 1994-04-12 1995-12-19 Hoechst Japan Ltd 骨粗鬆症治療剤
WO2003068205A1 (en) * 2002-02-14 2003-08-21 Kirin Beer Kabushiki Kaisha Compositions and foods for improving lipid metabolism

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018131389A (ja) * 2017-02-13 2018-08-23 サッポロホールディングス株式会社 アセトアルデヒドデヒドロゲナーゼ活性促進剤

Also Published As

Publication number Publication date
JPWO2009072576A1 (ja) 2011-04-28

Similar Documents

Publication Publication Date Title
WO2006096434A3 (en) Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
WO2006096439A3 (en) Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases
EP4512399A3 (en) Solid state forms of tafamidis and salts thereof
WO2007090393A3 (de) Pharmazeutische zubereitung auf basis vom mikrotabletten
WO2008088030A1 (ja) 血栓もしくは塞栓に関連する疾患の予防又は治療用組成物
WO2010049454A3 (en) Antimicrobial composition from copepods
WO2009117130A3 (en) Extended release forumulation containing a wax
WO2009129246A3 (en) Compositions and methods for preparing and using same
WO2007045252A3 (en) An edible composition
WO2011090270A3 (ko) 오스모틴을 포함하는 신경질환의 예방 및 치료용 조성물
WO2010111640A3 (en) Anti-influenza formulations and methods
MX2009012010A (es) Composiciones de vegetal o fruta aireadas, liofilizadas y metodos para elaboracion de las mismas.
WO2012091440A3 (en) Composition for improvement, treatment and prevention of gastrointestinal motility disorders
WO2010087565A3 (ko) 피페린의 신규한 용도
EP4327880A3 (en) Solid state form of ribociclib succinate
WO2011059292A3 (ko) 피부세포증식 촉진, 항산화 및 항알러지 효과가 우수한 알로에 베라 새순 농축물 또는 추출물
WO2008155998A1 (ja) 抗不安抗うつ剤
WO2007044950A3 (en) Crystalline forms of docetaxel and processes for their preparation
EP2644614A3 (en) Solid state forms of 5-azacytidine and processes for preparation thereof
WO2008129501A3 (en) Pharmaceutical compositions of duloxetine
WO2011043631A3 (ko) 호장근 추출물, 이의 분획물 또는 스틸벤계 화합물을 포함하는 감기의 예방 및 치료용 약학 조성물
WO2010127787A3 (de) Wirkstoffkombinationen mit insektiziden und akariziden eigenschaften
WO2010082689A3 (en) Gip-increase inhibitor
WO2009025792A3 (en) Crystalline forms cinacalcet fumarate and cinacalcet succinate and processes for preparation thereof
WO2011106630A3 (en) Chrysophaentin antimicrobial compounds that inhibit ftsz protein

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08857164

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2009544718

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08857164

Country of ref document: EP

Kind code of ref document: A1